ERS 2021: DAWn-AZITHRO – Azithromycin for Patients with COVID-19
TouchRESPIRATORY got the opportunity to catch up with Dr Iwein Gyselinck around the DAWn-AZITHRO trial of azithromycin antiviral therapy for patients with COVID-19.
Considering the Impact of Type 2 Diabetes Mellitus—Biological Mechanisms in COVID-19 Pathology
US Respiratory and Pulmonary Diseases. 2020;5(1):24-7 DOI: https://doi.org/10.17925/USPRD.2020.5.1.24
Impact of Smoking and Tobacco use on the Severity of COVID-19 Infection
US Respiratory and Pulmonary Diseases. 2020;5(1):12-4 DOI: https://doi.org/10.17925/USPRD.2020.5.1.12
COVID-19 Pandemic—Allergen-specific Immunotherapy Positioning in Respiratory Allergy
US Respiratory & Pulmonary Diseases. 2020;5(1):10-1 DOI: https://doi.org/10.17925/USPRD.18.104.22.168
Vaccine Candidates for COVID-19
Following her presentation at CHEST 2020, entitled ‘Current Vaccine Candidates for COVID-19: Preclinical and Clinical Data’, Julie Ake (Walter Reed Army Institute of Research, Silver Spring, MD, USA) talks to touchRESPIRATORY further about vaccines in development for COVID-19.
ATS 2021: Post-COVID-19 Interstitial Lung Syndrome
We were delighted to catch up with Dr Sara Tomassetti (Careggi University Hospital, Florence, Italy) around interstitial lung changes following SARS-CoV-2 infection.
Smoking as a Risk Factor for COVID-19 Infection and Severe Disease
We discuss with Dr. Filippos Filippids (Imperial College London, London, UK) what the literature has shown us so far about the link between smoking and COVID-19 disease.
Air Pollution and COVID-19 Mortality
We discuss with Prof. Sara De Matteis (University of Cagliari, Cagliari, Italy) what we know so far about the potential association between air pollution exposure and SARS-CoV-2 infection.
COVID-19 and Respiratory Disorders
On March 27 2020, we met with our Editorial Board member, Dr Anoop Nambiar (UT Health San Antonio, TX, USA) for a video interview around the impact COVID-19 is having on respiratory disorders such as asthma, COPD and ILF/IPD in the US.
COVID-19 and Cystic Fibrosis
Dr Jennifer Taylor-Cousar (National Jewish Health, Denver, CO, USA) explores what we have learnt so far about how COVID-19 is effecting patients with cystic fibrosis.
CME activities are developed by touchIME for touchRESPIRATORY.
Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!